CSIMarket


Inovio Pharmaceuticals Inc.  (INO)
Other Ticker:  
 


 

Inovio Pharmaceuticals Inc.

INO's Financial Statements and Analysis



Inovio Pharmaceuticals Inc. increased II. Quarter net loss per share of $-0.46 compare to net loss per share of $-0.39 recorded in the same quarter a year ago a decrease compare to $-0.36 realized in previous quarter.


II. Quarter
Earnings Per Share Revenues
$ -0.46 $  2 Mill
$-0.07     Unch.     +36.73 %



Inovio Pharmaceuticals's Revenue rose by 36.73 % in II. Quarter (Jun 30 2022) year on year, to $2 million and advanced by 88.98 % sequentially.


Inovio Pharmaceuticals is Expected to report next financial results on November 08, 2022.

More on INO's Income Statement



Inovio Pharmaceuticals's in II. Quarter recorded net loss of $-108.497 million, an increase from net loss of $-82.140 million in II. Quarter a year ago.

Sequentially net loss advanced

More on INO's Growth

In II. Quarter company's net cash and cash equivalents decreased by $-18 million, capital expenditures fell by 244.96%, to $-1 millions compare to same quarter a year ago and fell by 0.00% from I. Quarter (Mar 31 2022).

More on INO's Cash flow Statement


Inovio Pharmaceuticals Inc. does not pay out common stock dividend.

In trailing twelve-month period Inovio Pharmaceuticals Inc. payed $ -0.84 cash per share, on a free-cash flow basis .

Book value fell by -21.99 % sequentially to $1.27 per share, -22.12% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 1.21 per share from $ 1.56.

Company issued 16.34 million shares or 7.46 % in II. Quarter.


More on INO's Dividends

 Market Capitalization (Millions) 406
 Shares Outstanding (Millions) 235
 Total Debt (Millions $) 17
 Revenue (TTM) (Millions $) 5
 Net Income (TTM) (Millions $) -355
 Cash Flow (TTM) (Millions $) -18
 Capital Exp. (TTM) (Millions $) -2
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Inovio Pharmaceuticals Inc. does not pay out common stock dividend.

In trailing twelve-month period Inovio Pharmaceuticals Inc. payed $ -0.84 cash per share, on a free-cash flow basis .

Book value fell by -21.99 % sequentially to $1.27 per share, -22.12% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 1.21 per share from $ 1.56.

Company issued 16.34 million shares or 7.46 % in II. Quarter.


More on INO's Balance Sheets

 Market Capitalization (Millions) 406
 Shares Outstanding (Millions) 235
 Total Debt (Millions $) 17
 Revenue (TTM) (Millions $) 5
 Net Income (TTM) (Millions $) -355
 Cash Flow (TTM) (Millions $) -18
 Capital Exp. (TTM) (Millions $) -2
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SCKT's Profile

Stock Price

SCKT's Financials

Business Description

Fundamentals

Charts & Quotes

SCKT's News

Suppliers

SCKT's Competitors

Customers & Markets

Economic Indicators

SCKT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071